Skip to main content

Biotechnology ETFs Soar on Biogen’s New Alzheimer’s Drug

Biotechnology stocks and sector-related exchange traded funds stood out Friday after regulators breathed new life into Biogen (NasdaqGS: BIIB) and its partner Eisai Co. (ESALY) on a new Alzheimer’s drug candidate. Among the top performing non-leveraged ETFs of Friday, the VanEck Vectors...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.